Looking beyond VEGF to target BRB dysfunction in diabetic macular edema: Preventing vision loss

Are we fully addressing the biology driving diabetic macular edema (DME) or are we still over-relying on VEGF suppression alone? 👁️ In this on-demand CME activity, Dr. Diana Do examines the emerging science of blood–retinal barrier (BRB) dysfunction and what BRB restoration could mean for future DME management. Topics covered: • The epidemiology, burden and quality-of-life impact of DME in the USA • Clinical limitations of current anti-VEGF approaches and patient profiles where gaps are most evident • Novel BRB-targeted strategies, including Wnt signaling modulation, cellular senescence pathways and inflammatory cytokine inhibition As the field evolves, so does the need to rethink therapeutic targets in retinal disease. ▶ Watch now to access the full CME activity and claim credits: https://touchophthalmologyime.org/tar... This activity is jointly provided by USF Health and touchIME. This activity is for healthcare professionals based in the USA only. #DME #DiabeticMacularEdema #RetinaSpecialist #Ophthalmology #CME